Firm
As trade secret filings rise due to AI development and economic espionage concerns, firms are relying on proactive counselling to help clients navigate disputes
IP firm leaders share why they remain positive in the face of falling patent applications from US filers, and how they are meeting a rising demand from China
Mathew Lucas has joined Pearce IP after spending more than 25 years at Qantm IP-owned firm Davies Collison Cave
Abigail Wise shares her unusual pathway into the profession, from failing A-levels to becoming Lewis Silkin’s first female IP partner
Sponsored
Sponsored
-
Sponsored by Remfry & SagarBisman Kaur of Remfry & Sagar says recent reports indicate the development of India’s intellectual property culture is continuing apace through progress in areas such as R&D, enforcement, and patent and trademark filings -
Sponsored by Tilleke & GibbinsWith agriculture a vitally important sector of Cambodia’s economy, Sokmean Chea and Vongkhim Lay of Tilleke & Gibbins provide a guide to the registration of new plant varieties in light of significant developments
-
Sponsored by Tilleke & GibbinsLinh Duy Mai and Giang Hoang Bach of T&G Law Firm LLC (TGVN), the local associate firm of Tilleke & Gibbins, explain why Decree 147 is to be welcomed, although a key issue is unresolved
-
Sponsored by Gün and PartnersUğur Aktekin and Begüm Soydan Sayılkan of Gün + Partners highlight several decisions concerning the Turkish Patent and Trademark Office’s well-known trademark registry and say clarification of its standing is eagerly awaited
-
Sponsored by MaiwaldChristian Meyer and Gisela Grabow of Maiwald consider proposals under the European Commission’s Action Plan for Intellectual Property that aim to simplify extended protection for medicinal products through a unitary supplementary protection certificate
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Shipra Alisha Philip of RNA, Technology and IP Attorneys explore the factors driving rapid growth in India's medical tourism industry as fraudulent healthcare providers attempt to cash in
